---
title: Prevalence of Colon Cancer in Pyogenic Liver Abscess
nct_id: NCT02032914
overall_status: COMPLETED
sponsor: Inje University
study_type: OBSERVATIONAL
primary_condition: Cryptogenic Pyogenic Liver Abscess
countries: South Korea
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02032914.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02032914"
ct_last_update_post_date: 2016-03-01
last_seen_at: "2026-05-12T06:40:07.085Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Prevalence of Colon Cancer in Pyogenic Liver Abscess

**Official Title:** The Prevalence of Colonic Neoplasm in Cryptogenic Pyogenic Liver Abscess

**NCT ID:** [NCT02032914](https://clinicaltrials.gov/study/NCT02032914)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 62
- **Lead Sponsor:** Inje University
- **Collaborators:** Pusan National University Yangsan Hospital
- **Conditions:** Cryptogenic Pyogenic Liver Abscess
- **Start Date:** 2014-01
- **Completion Date:** 2016-02
- **CT.gov Last Update:** 2016-03-01

## Brief Summary

Although a proportion of pyogenic liver abscess may originated from colonic mucosal lesions, the prevalence of colonic neoplasm in the patients with pyogenic liver abscess are still not evaluated yet. Thus, our group will find the prevalence of colonic neoplasm in the group of cryptogenic pyogenic liver abscess by colonoscopic examination.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Pyogenic liver abscess radiologically and bacteriologically diagnosed

Exclusion Criteria:

* Amebic liver abscess
* Other causes of pyogenic liver abscess such as cholangitis, liver cancer, complication of transarterial chemoembolization or radiofrequency ablation to hepatocellular carcinoma
* Refusal to colonoscopic examination
* Inadequate general patient status to perform the colonoscopic examination
* Patient who has had the screening colonoscopic examination within 1 year and showed normal finding or had 1 or 2 colon polyp in adequate exam
```

## Arms

- **Colonoscopic examination group** — The patients diagnosed with cryptogenic pyogenic liver abscess

## Primary Outcomes

- **The prevalence of colonic neoplasm** _(time frame: within 6 weeks after diagnosis of pyogenic liver abscess)_

## Secondary Outcomes

- **Prevalence of colon polyp** _(time frame: Within 6 weeks at diagnosis of pyogenic liver abscess)_
- **Prevalence of colonic diverticulitis** _(time frame: Within 6 weeks at diagnosis of pyogenic liver abscess)_
- **Prevalence of inflammatory bowel disease** _(time frame: Within 6 weeks at diagnosis of pyogenic liver abscess)_
- **Prevalence of intestinal tuberculosis** _(time frame: Within 6 weeks at diagnosis of pyogenic liver abscess)_

## Locations (2)

- Pusan National Unversity Yangsan Hospital, Yangsan, Gyeongsangnam-do, South Korea
- Inje University Haeundae Paik Hospital, Busan, South Korea

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.pusan national unversity yangsan hospital|yangsan|gyeongsangnam-do|south korea` — added _(2026-05-12)_
- `locations.inje university haeundae paik hospital|busan||south korea` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02032914.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02032914*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*